Clinical Trial Update: Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19

View source ↗

Summary

This trial update notes that the University of Alberta–sponsored study NCT04732663 examining exertional dyspnea and exercise intolerance in COVID-19 has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea

Snippet

Sponsor: University of Alberta | Conditions: Covid19, Dyspnea | Status: COMPLETED